Targeting Apoptosis Resistance in Rhabdomyosarcoma

E-ISSN： 1873-5576|8|6|536-544

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.6, 2008-01, pp. : 536-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the fetal acetylcholine receptor in rhabdomyosarcoma

By Simon-Keller Katja Barth Stefan Vincent Angela Marx Alexander

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-03 ,pp. : 127-138

Informa Healthcare

Access to resources Recommend Favorite

Targeting apoptosis in cancer chemotherapy

By Makin Guy

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 73-84

Informa Healthcare

Access to resources Recommend Favorite

New approaches for pediatric rhabdomyosarcoma drug discovery: targeting combinatorial signaling

By Rengaswamy Venkatesh Kontny Udo Rössler Jochen

Expert Opinion on Drug Discovery, Vol. 6, Iss. 10, 2011-10 ,pp. : 1103-1125

Informa Healthcare

Access to resources Recommend Favorite

Targeting Apoptosis Pathways in Cancer Therapy

Current Cancer Drug Targets, Vol. 4, Iss. 7, 2004-11 ,pp. : 569-576

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the p53 Pathway of Apoptosis

Current Pharmaceutical Design, Vol. 16, Iss. 22, 2010-07 ,pp. : 2493-2503

Bentham Science Publishers

Access to resources Recommend Favorite